Literature DB >> 7608556

Regulation of cyclooxygenase-2 expression in normal human articular chondrocytes.

Y Geng1, F J Blanco, M Cornelisson, M Lotz.   

Abstract

This study analyzes cyclooxygenase II (COX-2) gene expression, protein synthesis, and PGE2 release in normal human articular chondrocytes. Stimulation of chondrocytes in primary culture resulted in a dose-dependent induction of COX-2 mRNA in response to IL-1 with an ED50 between 0.1 and 1 ng/ml. COX-2 mRNA was detectable after 2 h, reached high levels at 6 h, and showed a remarkably long duration of expression for at least 72 h. Analysis of other extracellular stimuli showed that COX-2 mRNA was inducible by other cytokines including TNF-alpha, IL-6, and LIF and by bacterial LPS. Dexamethasone completely inhibited IL-1-induced COX-2 mRNA expression. Analysis of signaling pathways showed that PMA and calcium ionophore A23187, but not dibutyryl cAMP, induced COX-2 mRNA. The combination of IL-1 and A23187 resulted in synergistic increases. IL-1 effects were not reduced by the protein kinase C inhibitor staurosporine or by the protein kinase A inhibitor H89 but blocked by the protein tyrosine kinase inhibitor herbimycin A. COX-2 protein was detected at 71 kDa by Western blotting in IL-1-stimulated, and to almost similar levels in A23187-treated, cells. Flow cytometric analysis showed that after IL-1 stimulation 78% of the chondrocytes expressed COX-2 protein. The patterns of COX-2 protein expression and the levels of PGE2 release correlated with the effects of the different stimuli and inhibitors on mRNA expression.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7608556

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  29 in total

1.  Selenomethionine inhibits IL-1β inducible nitric oxide synthase (iNOS) and cyclooxygenase 2 (COX2) expression in primary human chondrocytes.

Authors:  A W M Cheng; T V Stabler; M Bolognesi; V B Kraus
Journal:  Osteoarthritis Cartilage       Date:  2010-10-28       Impact factor: 6.576

2.  A prospective randomised multicentre study comparing continuous and intermittent treatment with celecoxib in patients with osteoarthritis of the knee or hip.

Authors:  F P Luyten; P Geusens; M Malaise; L De Clerck; R Westhovens; F Raeman; D Vander Mijnsbrugge; L Mathy; J P Hauzeur; F De Keyser; F Van den Bosch
Journal:  Ann Rheum Dis       Date:  2006-06-30       Impact factor: 19.103

3.  Intercellular calcium signalling between chondrocytes and synovial cells in co-culture.

Authors:  P D'andrea; A Calabrese; M Grandolfo
Journal:  Biochem J       Date:  1998-02-01       Impact factor: 3.857

4.  Cyclooxygenase-1 and -2 are expressed by human T cells.

Authors:  J L Pablos; B Santiago; P E Carreira; M Galindo; J J Gomez-Reino
Journal:  Clin Exp Immunol       Date:  1999-01       Impact factor: 4.330

Review 5.  Cyclo-oxygenase-2: pharmacology, physiology, biochemistry and relevance to NSAID therapy.

Authors:  J A Mitchell; T D Warner
Journal:  Br J Pharmacol       Date:  1999-11       Impact factor: 8.739

6.  Effects of insulin-like growth factor-1 and dexamethasone on cytokine-challenged cartilage: relevance to post-traumatic osteoarthritis.

Authors:  Y Li; Y Wang; S Chubinskaya; B Schoeberl; E Florine; P Kopesky; A J Grodzinsky
Journal:  Osteoarthritis Cartilage       Date:  2014-11-11       Impact factor: 6.576

Review 7.  Low-grade inflammation as a key mediator of the pathogenesis of osteoarthritis.

Authors:  William H Robinson; Christin M Lepus; Qian Wang; Harini Raghu; Rong Mao; Tamsin M Lindstrom; Jeremy Sokolove
Journal:  Nat Rev Rheumatol       Date:  2016-08-19       Impact factor: 20.543

8.  Selective inhibition of cyclooxygenase (COX)-2 reverses inflammation and expression of COX-2 and interleukin 6 in rat adjuvant arthritis.

Authors:  G D Anderson; S D Hauser; K L McGarity; M E Bremer; P C Isakson; S A Gregory
Journal:  J Clin Invest       Date:  1996-06-01       Impact factor: 14.808

9.  Cellulose-based hydrogels as body water retainers.

Authors:  A Sannino; A Esposito; L Nicolais; M A Del Nobile; A Giovane; C Balestrieri; R Esposito; M Agresti
Journal:  J Mater Sci Mater Med       Date:  2000-04       Impact factor: 3.896

10.  Exaggerated expression of inflammatory mediators in vasoactive intestinal polypeptide knockout (VIP-/-) mice with cyclophosphamide (CYP)-induced cystitis.

Authors:  Beatrice M Girard; Susan E Malley; Karen M Braas; James A Waschek; Victor May; Margaret A Vizzard
Journal:  J Mol Neurosci       Date:  2008-05-16       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.